Publicacions en què col·labora amb Josep Redón Más (20)

2022

  1. Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión - Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA)

    Hipertensión y riesgo vascular, Vol. 39, Núm. 4, pp. 174-194

2018

  1. Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial

    Hipertensión y riesgo vascular, Vol. 35, Núm. 3, pp. 119-129

2014

  1. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897

  2. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750

2013

  1. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    European Heart Journal, Vol. 34, Núm. 28, pp. 2159-2219

  2. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus

    JAMA Internal Medicine, Vol. 173, Núm. 18, pp. 1682-1692

2009

  1. Differences between office and ambulatory control of hypertension in very elderly patients. The CARDIORISC - MAPAPRES project

    Medicina Clinica, Vol. 133, Núm. 20, pp. 769-776

  2. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients

    Hypertension, Vol. 53, Núm. 3, pp. 466-472

  3. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document

    Journal of Hypertension, Vol. 27, Núm. 11, pp. 2121-2158

  4. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force documental

    Blood Pressure, Vol. 18, Núm. 6, pp. 308-347

  5. Response to nondipping in patients with hypertension

    Hypertension

2008

  1. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

    The Lancet, Vol. 372, Núm. 9644, pp. 1174-1183

  2. European society of hypertension guidelines for blood pressure monitoring at home: A summary report of the second international consensus conference on home blood pressure monitoring

    Journal of Hypertension, Vol. 26, Núm. 8, pp. 1505-1526

  3. Telmisartan, ramipril, or both in patients at high risk for vascular events

    New England Journal of Medicine, Vol. 358, Núm. 15, pp. 1547-1559

2007

  1. Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme

    Vascular Health and Risk Management, Vol. 3, Núm. 1, pp. 1-9

2006

  1. Effect of NSAID on blood pressure among hypertensive patients with a high cardiovascular risk

    Anales de Medicina Interna, Vol. 23, Núm. 9

2004

  1. Microalbuminuria as an intermediate endpoint in essential hypertension: Evidence is coming

    Journal of Hypertension

2001

  1. 1990-2000: una década de la hipertensión española

    Drug Farma

1998

  1. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: A prospective study

    Hypertension, Vol. 31, Núm. 2, pp. 712-718

1994

  1. Antihpertensive activity of verapamil: Impact of dietary sodium (Journal of Hypertension (1993) 11 (665-671)

    Journal of Hypertension